James Paluskiewicz

• Secured multiple invitations for clients to voluntarily appear before Congressional committees and counseled their testimony.
• Provided strategic counsel to a leading medical device trade association on Medicare reimbursement and coverage policies related to cutting edge technologies.
• Helped client navigate a committee oversight investigation on a priority issue to the industry.
• Facilitated inclusion of client priority legislative language into the FY22 omnibus funding bill.
• Developed and executed a strategy for a health care provider group seeking revisions to Medicare clinical regulations and provides ongoing technical expertise.
• Called on by committee staff and congressional caucuses to brief staff as a subject matter expert on Medicare reimbursement and payment policy.
• Drafted legislative language for bill introduction, amendment consideration, and comment letters.
• Led negotiations on and oversaw the implementation of all health-related provisions in five legislative vehicles responding to the COVID-19 pandemic.
• Negotiated the permanent repeal and replace of both Medicare’s sustainable growth rate formula and its outpatient therapy caps.
• Spearheaded successful congressional efforts to end surprise medical bills.
• Worked extensively on the FDA Safety and Innovation Act, 21st Century Cures Act, the Medicare Access and CHIP Reauthorization Act, the Bipartisan Budget Act of 2018, the Comprehensive Addiction and Recovery Act, and the SUPPORT Act.

James “JP” Paluskiewicz is a senior policy advisor in the Health Care group. JP advises health care clients on legislative and public policy matters before Congress, the Administration, and other government agencies. JP devises strategies for effective outreach and messaging to assist health care clients in navigating complex legislation and regulation. He develops and executes legislative and regulatory solutions on behalf of health care provider groups, health care systems, hospitals, biopharmaceutical and medical device companies, and health payers while working directly with policymakers on the Hill and in the Administration to secure their passage and implementation.

JP was chief counsel on the House Energy and Commerce Committee, Health Subcommittee and oversaw all policy matters under the committee’s jurisdiction, including legislation affecting the Food and Drug Administration, Medicare, Medicaid, private insurance, health information technology, and public health. He managed the committee’s health agenda, policy development, and legislative strategy for Republicans. He was also the sole policy staffer overseeing Medicare Parts B and D and health information technology. During his tenure on Capitol Hill, JP developed and shepherded numerous policies throughout the legislative process.

JP is an adjunct professor at The George Washington University’s Graduate School of Political Management and Milken Institute School of Public Health. JP regularly serves as a panelist and speaker on policy matters to health care audiences throughout the Washington, D.C. area.

Education

• The George Washington University (M.A., 2006)
• American University (B.A., 2002)